Dror Bashan

Track

Insider profile

Currently holds a position at Protalix Biotherapeutics Inc

Performance

Overall performance
2.6
Performance over holding periods
2.6
30 days 90 days 120 days
Average return -6% 8.2% 15.1%
Success rate 34% 68% 82%
Transactions
4 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
President, Chief Executive Officer, Director Protalix Biotherapeutics Inc June 30, 2019 -
Dror Bashan's trades of Protalix Biotherapeutics Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Purchase
Price
119.29
Quantity 56,389 -12.7%
Value US$1,992,998
Transaction date
Purchase
Price
209.98
Quantity 75,373 -18.6%
Value US$4,943,017
Transaction date
Purchase
Price
152.71
Quantity 75,372 -7.6%
Value US$4,786,765
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2025-12-23 2025-12-19
B Purchase
56,389 -12.7%
119.29
US$1,992,998 		56,389 -12.7% 119.29 US$1,992,998
2023-10-20 2023-10-19
B Purchase
75,373 -18.6%
209.98
US$4,943,017 		75,373 -18.6% 209.98 US$4,943,017
2023-10-20 2023-10-19
B Purchase
75,372 -7.6%
152.71
US$4,786,765 		75,372 -7.6% 152.71 US$4,786,765
2022-04-13 2022-04-11
B Purchase
68,000 +inf%
1.50
US$102,000 		68,000 +inf% 1.50 US$102,000